Status:

TERMINATED

Observational Study to Evaluate Allogeneic HSCT Outcomes for Cerebral Adrenoleukodystrophy (CALD)

Lead Sponsor:

Genetix Biotherapeutics Inc.

Conditions:

X-Linked Adrenoleukodystrophy (X-ALD)

Cerebral Adrenoleukodystrophy (CALD)

Eligibility:

MALE

Up to 17 years

Brief Summary

Study ALD-103 will be a multi-site, global, prospective and retrospective data collection study that is designed to evaluate outcomes of allo-HSCT in male subjects with CALD ≤17 years of age.

Eligibility Criteria

Inclusion

  • Provide informed consent from a competent custodial parent or guardian with legal capacity to execute a local Institutional Review Board (IRB)/Independent Ethics Committee (IEC) approved consent. In addition, informed assent will be sought from capable subjects, in accordance with the directive of the institution's IRB/IEC and all other local requirements.
  • Be male and ≤17 years of age at the time of treatment, for retrospective and partial prospective/retrospective subjects, or at the time of parental/guardian consent and, where appropriate, subject assent, for prospective subjects.
  • Have a confirmed diagnosis of CALD as defined by abnormal VLCFA profile and cerebral lesion on brain MRI.
  • Depending on the cohort, the subject must:
  • Be scheduled for allo-HSCT evaluation at a study site (prospective cohort only),
  • Have received an allo-HSC infusion and be consented in time to complete the Month 24 Visit on study (partial prospective/retrospective cohort only), or
  • Have received their most recent allo-HSC infusion on or after January 1, 2013 (retrospective cohort only).

Exclusion

  • Previous treatment with a gene therapy product.
  • Receipt of an experimental transplantation procedure.

Key Trial Info

Start Date :

April 1 2015

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 6 2019

Estimated Enrollment :

59 Patients enrolled

Trial Details

Trial ID

NCT02204904

Start Date

April 1 2015

End Date

December 6 2019

Last Update

May 21 2020

Active Locations (13)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 4 (13 locations)

1

Children's Hospital Los Angeles

Los Angeles, California, United States, 90027

2

Stanford University

Palo Alto, California, United States, 94304

3

Boston Children's Hospital/Massachusetts General Hospital

Boston, Massachusetts, United States, 02141

4

University of Minnesota

Minneapolis, Minnesota, United States, 55455

Observational Study to Evaluate Allogeneic HSCT Outcomes for Cerebral Adrenoleukodystrophy (CALD) | DecenTrialz